Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Corcept Therapeutics (CORT) Inventory Average (2016 - 2025)

Historic Inventory Average for Corcept Therapeutics (CORT) over the last 10 years, with Q3 2025 value amounting to $12.3 million.

  • Corcept Therapeutics' Inventory Average rose 5015.24% to $12.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $12.3 million, marking a year-over-year increase of 5015.24%. This contributed to the annual value of $10.1 million for FY2024, which is 4563.99% up from last year.
  • As of Q3 2025, Corcept Therapeutics' Inventory Average stood at $12.3 million, which was up 5015.24% from $13.3 million recorded in Q2 2025.
  • Corcept Therapeutics' Inventory Average's 5-year high stood at $13.4 million during Q1 2025, with a 5-year trough of $4.8 million in Q2 2021.
  • Over the past 5 years, Corcept Therapeutics' median Inventory Average value was $6.7 million (recorded in 2023), while the average stood at $7.5 million.
  • Its Inventory Average has fluctuated over the past 5 years, first plummeted by 618.58% in 2021, then surged by 7949.06% in 2025.
  • Quarter analysis of 5 years shows Corcept Therapeutics' Inventory Average stood at $5.0 million in 2021, then grew by 21.68% to $6.1 million in 2022, then rose by 25.5% to $7.6 million in 2023, then surged by 34.24% to $10.2 million in 2024, then increased by 20.35% to $12.3 million in 2025.
  • Its last three reported values are $12.3 million in Q3 2025, $13.3 million for Q2 2025, and $13.4 million during Q1 2025.